Marco Ravanelli

University of Brescia — Italy

Medicine · Health Sciences

27h-index2.5kcitations179works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Surgical Oncology(47), Head and Neck Cancer Studies(40), Radiomics and Machine Learning in Medical Imaging(32), Sinusitis and nasal conditions(20), Meningioma and schwannoma management(20)

Publications179 total

Quantitative Anatomical Comparison of Microsurgical Transcranial, Endoscopic Endonasal and Transorbital Approaches to the Orbit and Surrounding Skull Base Regions
Journal of Neurological Surgery Part B Skull Base·2026
Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy
Breast Cancer Research and Treatment·2026· 1 cited
T2 hypointense lesions in the parapharyngeal space: a diagnostic challenge
La radiologia medica·2025Open Access
Independent role of Follicle Stimulating Hormone (FSH) variations as a predictive factor for cardiovascular events in metastatic Hormone-Sensitive Prostate Cancer (mHSPC) patients given androgen deprivation plus enzalutamide
European Urology Open Science·2025Open Access
Radiomics in Pituitary Adenomas: A Systematic Review of Clinical Applications and Predictive Models
Journal of Clinical Medicine·2025· 2 citedOpen Access
371P Independent predictive role of obesity on vertebra fracture risk in breast cancer patients undergoing adjuvant aromatase inhibitor therapy
Annals of Oncology·2025
2469P Bone marrow adipose tissue (BMAT) assessment in metastatic hormone-sensitive prostate cancer (mHSPC) patients randomized to androgen deprivation therapy + enzalutamide +/- zoledronic acid - The BonEnza study
Annals of Oncology·2025
Haemodynamic numerical simulation of hybrid surgical repairs for thoracoabdominal aortic aneurysms
Computer Methods and Programs in Biomedicine·2025
Selected laryngeal squamous cell carcinomas with laryngeal mobility impairment are suitable for curative larynx-preservation treatment
Oral Oncology·2025· 2 citedOpen Access
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2
Oral Oncology·2025· 1 cited
Erratum to “Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: Consensus statements from an Italian expert panel” [Crit. Rev. Oncol. / Hematol. 210 (2025) 104709]
Critical Reviews in Oncology/Hematology·2025
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial
Prostate Cancer and Prostatic Diseases·2025· 2 cited
2747 Radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on MR-linac: preliminary outcomes and comparison with helical tomotherapy
Radiotherapy and Oncology·2025
402P Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy
ESMO Open·2025Open Access
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study
European Urology Oncology·2025· 3 citedOpen Access
Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma
Scientific Reports·2025· 7 citedOpen Access
Nodal status in major salivary gland cancer: External validation of a novel N- classification
European Journal of Surgical Oncology·2025· 2 cited
Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: Consensus statements from an Italian expert panel
Critical Reviews in Oncology/Hematology·2025· 3 citedOpen Access
Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: Preliminary outcomes and comparison with helical tomotherapy
Clinical and Translational Radiation Oncology·2025· 3 citedOpen Access
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial
European Journal of Cancer·2025· 9 cited
page 1 of 9Next →

Frequent Co-authors

Roberto Maroldi(32), Davide Farina(29), Piero Nicolai(20), Davide Mattavelli(15), Alberto Schreiber(13), Marco Ferrari(12), Andrea Borghesi(9), Vittorio Rampinelli(9), Luigi Fabrizio Rodella(9), Francesco Doglietto(8), Paolo Bossi(7), Davide Lombardi(6), Giorgio Maria Agazzi(6), Francesco Belotti(6), Davide Lancini(6), Marco Maria Fontanella(6), Barbara Buffoli(6), Alberto Paderno(6), Alfredo Berruti(5), Simonetta Battocchio(5)